Astrana Health, Inc. logo ASTH - Astrana Health, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 10
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $51.80 DETAILS
HIGH: $65.00
LOW: $41.00
MEDIAN: $53.00
CONSENSUS: $51.80
UPSIDE: 31.64%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2
Revenue
Revenue 972.5 965.1 950.5 956.0 654.8 620.4 665.2 478.7 486.3 404.4 353.0 348.2 348.2 337.2 294.2 317.0 269.7 263.3 195.1 227.1 175.6
Cost of Revenue 868.5 874.8 871.9 874.5 576.8 549.1 602.2 405.2 420.2 335.5 314.1 275.4 292.9 289.4 253.1 240.8 230.1 220.7 171.8 147.5 136.2
Gross Profit 104.0 90.3 78.6 81.6 78.0 71.3 63.0 73.5 66.0 68.9 39.0 72.8 55.3 47.8 41.1 76.2 39.6 42.5 23.3 79.6 39.4
Operating Expenses
R&D Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SG&A Expenses 54.1 61.7 9.5 113.1 50.7 43.9 41.6 37.8 36.0 38.7 37.9 29.4 24.1 21.2 24.4 21.4 19.9 11.9 16.6 21.8 14.2
Other Expenses 15.6 0 50.7 (50.7) 6.9 6.8 20.7 7.3 0 0 4.9 4.3 4.2 4.3 4.1 4.8 4.4 4.4 4.4 4.7 4.2
Operating Expenses 69.7 61.7 60.2 62.4 57.6 50.7 62.3 45.1 36.0 38.7 42.9 33.7 28.3 25.5 28.5 26.1 24.2 16.3 21.0 26.5 18.4
Operating Income
Operating Income 34.3 28.5 18.4 19.2 20.3 20.6 0.7 28.4 30.1 30.1 (3.9) 39.1 27.0 22.4 12.6 50.1 15.4 26.2 2.2 53.2 21.0
Interest Expense 16.0 16.1 17.5 17.7 7.4 7.3 8.1 8.9 8.6 7.6 5.4 3.8 3.6 3.3 2.6 2.4 1.9 1.1 1.1 1.0 1.9
Interest Income 5.9 3.8 4.0 3.5 2.3 2.3 3.2 3.8 3.5 4.0 4.6 3.3 3.3 3.0 1.3 0.2 0.4 0.0 0.2 0.4 0.6
Profitability
EBITDA 43.2 51.3 41.4 39.0 31.1 23.8 14.3 42.9 47.9 36.7 11.2 46.1 39.4 27.0 17.1 48.4 22.8 23.7 (17.0) 0.1 90.5
EBIT 43.2 35.8 25.0 23.4 24.2 16.9 6.2 35.7 40.5 31.6 6.3 41.8 35.1 22.7 13.0 43.7 18.5 19.3 (21.4) (4.5) 86.3
Income Before Tax 27.2 19.7 7.5 5.7 16.8 9.6 (1.9) 26.8 31.9 24.0 0.9 38.0 31.5 19.4 10.5 41.3 16.6 18.3 (22.4) (5.5) 84.5
Income Tax Expense 8.8 6.6 0.9 4.6 6.6 3.4 5.9 7.8 10.0 7.1 1.0 10.0 14.0 6.9 10.0 17.4 5.4 6.8 (3.1) (0.1) 24.9
Net Income 19.7 14.4 6.0 0.4 9.4 6.7 (7.0) 16.1 19.2 14.8 12.4 22.1 13.2 13.1 (2.6) 23.2 11.9 13.8 13.8 34.3 12.7
Per Share Data
EPS (Basic) 0.40 0.30 0.12 0.01 0.19 0.14 -0.14 0.34 0.40 0.31 0.26 0.47 0.28 0.28 -0.06 0.58 0.25 0.32 0.31 0.77 0.29
EPS (Diluted) 0.40 0.29 0.12 0.01 0.19 0.14 -0.14 0.33 0.40 0.31 0.26 0.47 0.28 0.28 -0.06 0.56 0.25 0.31 0.30 0.74 0.28
Shares Outstanding 49.1 48.9 49.2 49.2 49.2 48.5 47.9 47.7 47.6 47.9 47.5 46.5 46.5 46.6 46.6 44.9 44.9 44.7 44.4 44.3 44.2
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2
Current Assets
Cash & Cash Equivalents 400.8 478.4 429.5 462.2 339.7 258.5 288.5 348.0 325.3 334.8 293.8 273.9 293.9 274.6 288.0 184.0 234.2 237.9 233.1 204.8 177.3
Short-Term Investments 0 0 0 1.2 2.4 2.4 2.4 2.4 2.4 2.5 2.5 3.0 3.8 4.1 5.6 33.3 39.5 42.9 53.4 128.6 187.2
Net Receivables 492.5 500.1 407.6 397.0 365.3 328.6 324.8 226.1 225.2 184.2 147.8 185.3 151.9 153.8 119.7 214.6 174.7 148.9 99.3 82.2 93.9
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0 25.6 26.3 23.2 21.8 23.7 22.9 20.5 16.2 15.7 17.4 14.0 15.4 21.5 14.8 0 0 0 0 0 0
Total Current Assets 919.2 1,004.1 863.3 883.6 729.2 613.3 638.5 597.0 569.1 537.2 461.5 476.2 465.1 454.7 428.1 443.6 461.0 444.4 404.5 427.2 470.6
Non-Current Assets
Property, Plant & Equipment 101.8 93.5 94.4 90.1 48.4 47.5 46.9 45.3 39.1 47.1 44.6 150.1 141.8 131.8 129.0 120.5 106.8 85.1 68.6 65.4 57.7
Goodwill 887.0 874.8 863.9 863.3 416.9 416.4 419.3 409.7 409.6 410.3 278.8 275.5 274.0 276.0 269.1 257.5 253.3 252.4 246.4 243.4 239.1
Intangible Assets 243.3 257.1 271.0 285.1 105.7 111.9 118.2 109.1 116.2 119.7 71.6 74.2 74.4 77.7 76.9 73.2 76.7 80.1 82.8 83.6 80.2
Long-Term Investments 27.8 81.2 25.6 77.9 47.4 46.9 15.4 43.5 92.4 90.7 32.2 47.3 48.7 44.0 42.7 39.9 44.7 45.3 42.6 45.9 38.3
Other Non-Current Assets 76.8 48.1 100.4 37.2 94.8 95.2 96.0 80.8 26.0 (98.5) 2.2 8.9 23.2 5.4 4.6 8.7 8.6 5.0 22.4 5.8 8.7
Total Non-Current Assets 1,362.9 1,354.7 1,355.3 1,353.6 713.2 718.0 716.4 688.4 683.3 689.1 471.9 597.0 562.1 534.9 538.1 499.8 490.0 467.9 462.9 444.1 423.9
Total Assets 2,282.1 2,358.8 2,218.7 2,237.2 1,442.3 1,331.3 1,354.9 1,285.4 1,252.5 1,226.3 933.4 1,073.3 1,027.2 992.6 966.2 943.4 951.1 912.3 867.4 871.3 894.4
Current Liabilities
Account Payables 245.9 54.3 44.8 58.5 14.3 14.9 15.2 36.9 38.2 84.9 9.1 9.2 9.9 13.9 10.5 25.4 11.3 9.9 5.5 23.1 11.2
Short-Term Debt 53.8 47.9 47.9 47.9 12.5 12.5 9.4 15 17 20.8 19.5 3.0 2.6 0.6 0.6 3.2 2.4 1.5 0.8 0.2 0.2
Deferred Revenue 0 0 2.7 0 0 0.7 1.6 2.2 2.6 3.0 0.7 0.8 0.6 1.7 0.5 0.5 20.0 20.0 16.8 17.3 29.6
Other Current Liabilities 17.4 489.0 391.8 385.8 337.8 246.0 241.1 208.1 199.5 223.1 164.0 140.2 113.4 110.2 113.2 104.2 121.2 105.4 65.9 51.4 66.2
Total Current Liabilities 747.6 745.4 615.3 629.9 459.7 361.3 365.6 312.9 309.8 355.3 218.7 203.0 185.8 165.0 148.6 156.2 185.2 160.4 114.7 116.8 128.1
Non-Current Liabilities
Long-Term Debt 882.6 979.8 990.9 1,002.0 401.1 403.9 425.3 423.1 425.0 368.4 258.9 206.2 205.1 204.9 203.4 199.2 199.1 183.1 182.9 182.8 182.7
Deferred Tax Liabilities 8.8 7.4 5.5 4.4 2.6 4.2 4.6 2.9 3.2 3.8 4.1 12.1 12.3 3.7 14.2 4.7 9.3 9.7 30.1 19.6 21.2
Other Non-Current Liabilities 10.4 18.8 17.1 15.9 12.3 14.7 14.0 7.5 7.7 7.7 3.6 14.1 21.4 21.8 20.3 13.0 13.7 13.7 14.8 6.2 1.2
Total Non-Current Liabilities 935.9 1,036.0 1,045.1 1,052.5 444.7 452.3 475.1 465.3 463.9 418.6 303.9 254.7 257.8 249.7 259.1 233.9 240.0 220.2 242 222.7 219.9
Total Liabilities 1,683.5 1,781.4 1,660.3 1,682.5 904.4 813.5 840.7 778.3 773.8 773.9 522.6 457.6 443.6 414.7 407.7 390.1 425.2 380.7 356.7 339.5 348.0
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings 342.4 322.7 308.4 302.5 302.2 292.9 286.3 293.2 277.1 258.0 243.1 230.8 208.7 207.3 182.4 195.3 169.3 157.9 137.2 129.9 95.6
Accumulated Other Comprehensive Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity 830.2 800.3 779.3 775.5 765.5 745.4 712.7 704.6 678.9 653.5 614.2 593.7 566.0 560.0 542.6 510.4 480.0 474.0 448.2 435.9 401.4
Total Liabilities & Equity 2,282.1 2,358.8 2,218.7 2,237.2 1,442.3 1,331.3 1,354.9 1,285.4 1,252.5 1,226.3 933.4 1,073.3 1,027.2 992.6 966.2 943.4 951.1 912.3 867.4 871.3 894.4
Debt Metrics
Total Debt 979.4 1,065.2 1,078.1 1,087.2 447.6 451.4 471.8 475.8 475.5 433.6 321.0 235.6 230.3 228.7 229.4 223.1 223.2 201.5 201.0 199.9 200.6
Net Debt 578.6 586.8 648.7 625.0 107.9 192.8 183.4 127.8 150.1 98.8 27.2 (38.4) (63.6) (45.9) (58.7) 39.1 (11.0) (36.4) (32.1) (4.9) 23.3
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2
Operating Activities
Net Income 31.6 14.4 6.6 1.1 10.2 6.2 (7.8) 23.7 21.9 16.9 (0.1) 28.0 17.5 12.5 0.5 23.9 11.3 11.4 (19.3) (5.4) 59.5
Depreciation & Amortization 31.0 15.5 16.4 15.6 6.9 6.8 8.1 7.3 7.4 5.1 4.9 4.3 4.2 4.3 4.1 4.8 4.4 4.4 4.4 4.7 4.2
Stock-Based Compensation 21.7 9.9 11.4 7.7 11.7 7.8 15.2 6.2 7.4 5.7 8.7 5.7 4.2 3.4 5.6 3.5 3.9 3.1 2.4 1.4 1.6
Change in Working Capital 18.9 26.5 (39.2) (15.4) 58.9 (8.0) (29.5) 36.1 (13.0) (23.2) 11.4 (25.1) 7.2 (16.9) 77.4 (68.0) (10.0) (4.8) (13.2) (4.7) 7.9
Other Non-Cash Items (5.1) (0.1) 1.4 4.0 4.8 4.1 (0.3) (38.9) (0.5) 8.7 2.9 2.7 (3.3) 4.1 2.7 6.4 (1.7) 7.8 26.3 58.7 (63.1)
Operating Cash Flow 100.8 68.1 (2.9) 10.0 90.9 16.6 (10.9) 34.0 23.2 6.0 19.3 15.4 25.8 7.7 84.9 (35.9) 9.0 24.0 (12.2) 51.2 21.3
Investing Activities
Capital Expenditure (7.9) (4) (3.1) (2.6) (1.4) (3.1) (2.5) (2.3) (2.8) (0.4) (7.1) (4.1) (2.5) (14.9) (0.9) (3.2) (1.4) (17.5) (2.8) (9.1) (7.3)
Acquisitions (3.7) 0 (0.1) (548.6) 0.0 0 (34.7) (1.0) (73.8) (50.5) (1.8) (5.7) 0.3 (0.3) (11.1) (4.9) (0.1) (2.4) (1.5) (7.8) 1.5
Purchases of Investments 0 0 0 0 0.0 (0.0) 3.9 (3.9) (2.5) (0.0) (2.0) (0.1) (3.0) (1) (0.1) 0 (1.7) (0.0) (27.2) 4.1 (4.8)
Sales/Maturities of Investments 0 0 0 15.1 (0.1) 0 0 0.1 0 0 0.5 0 0 0 25.2 (0.0) 6.5 0 66.5 0 0
Other Investing Activities 2.5 1.2 2.1 1.5 0.4 0.7 0 (1.0) (0.8) (20.0) (1.0) (24.9) 0.0 2.1 0.0 0.0 4.2 0.2 2.6 0.0 0.0
Investing Cash Flow (9.1) (2.8) (1.1) (534.5) (1.0) (2.4) (33.3) (8.1) (79.9) (70.9) (11.4) (34.9) (5.2) (14.0) 13.2 (8.1) 7.5 (19.7) 37.6 (12.7) (10.5)
Financing Activities
Net Debt Issuance (103.9) (12.0) (12.0) 672.6 (3.0) (16.4) (3.9) (2.4) 53.0 106.3 77.0 1.1 (0.2) 1.3 1.3 (2.9) 0.2 0.5 0.4 (0.1) (56.5)
Stock Repurchased (4.4) (2.9) (15.4) (0.5) 1.3 (1.3) (0.2) (0.7) (3.6) 0 (0.5) (0.1) 0 (9.5) 0.4 (0.2) (9.2) (0.2) 0 (2.8) (2.6)
Dividends Paid (0.2) (0.1) (1.6) (0.1) (0.8) (5.5) (1.9) (0.2) 0 (0.1) (59.8) (2.3) (0.7) (0.1) (1.4) (0.1) (11.4) (1.2) 0 (10.0) (21.1)
Other Financing Activities (11.5) (1.0) 2.6 (23.5) (5.9) (21.0) (9.8) 0.1 (2.2) 0.1 (5.0) 0.8 (0.1) 1.2 5.5 (3.1) 0.2 1.4 0.1 1.8 (0.0)
Financing Cash Flow (120.0) (16.0) (26.3) 648.5 (8.7) (44.2) (15.3) (3.2) 47.3 106.2 12.0 (0.5) (1.0) (7.1) 5.9 (6.3) (20.2) 0.5 2.9 (11.0) (39.4)
Cash Position
Net Change in Cash (28.3) 48.9 (30.3) 122.5 81.2 (29.9) (59.5) 22.7 (9.5) 41.0 19.9 (20.0) 19.7 (13.4) 104.0 (50.2) (3.7) 4.8 28.3 27.5 (28.6)
Cash at Beginning 434.0 429.5 464.3 339.7 258.5 289.1 348.6 326.0 335.4 293.8 274.3 294.3 274.6 288.0 184.0 234.2 237.9 233.1 204.8 177.3 205.9
Cash at End 405.7 478.4 434.0 462.2 339.7 259.2 289.1 348.6 326.0 334.8 294.2 274.3 294.3 274.6 288.0 184.0 234.2 237.9 233.1 204.8 177.3
Free Cash Flow 92.9 64.1 (6.0) 7.4 89.5 13.6 (13.5) 31.7 20.4 5.6 12.2 11.3 23.3 (7.1) 84.1 (39.1) 7.7 6.5 (15.0) 42.2 14.1
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2
Income Statement
Revenue 972.5 965.1 950.5 956.0 654.8 620.4 665.2 478.7 486.3 404.4 353.0 348.2 348.2 337.2 294.2 317.0 269.7 263.3 195.1 227.1 175.6
Gross Profit 104.0 90.3 78.6 81.6 78.0 71.3 63.0 73.5 66.0 68.9 39.0 72.8 55.3 47.8 41.1 76.2 39.6 42.5 23.3 79.6 39.4
Operating Income 34.3 28.5 18.4 19.2 20.3 20.6 0.7 28.4 30.1 30.1 (3.9) 39.1 27.0 22.4 12.6 50.1 15.4 26.2 2.2 53.2 21.0
Net Income 19.7 14.4 6.0 0.4 9.4 6.7 (7.0) 16.1 19.2 14.8 12.4 22.1 13.2 13.1 (2.6) 23.2 11.9 13.8 13.8 34.3 12.7
EPS (Diluted) 0.40 0.29 0.12 0.01 0.19 0.14 -0.14 0.33 0.40 0.31 0.26 0.47 0.28 0.28 -0.06 0.56 0.25 0.31 0.30 0.74 0.28
Balance Sheet
Cash & Equivalents 400.8 478.4 429.5 462.2 339.7 258.5 288.5 348.0 325.3 334.8 293.8 273.9 293.9 274.6 288.0 184.0 234.2 237.9 233.1 204.8 177.3
Total Assets 2,282.1 2,358.8 2,218.7 2,237.2 1,442.3 1,331.3 1,354.9 1,285.4 1,252.5 1,226.3 933.4 1,073.3 1,027.2 992.6 966.2 943.4 951.1 912.3 867.4 871.3 894.4
Total Debt 979.4 1,065.2 1,078.1 1,087.2 447.6 451.4 471.8 475.8 475.5 433.6 321.0 235.6 230.3 228.7 229.4 223.1 223.2 201.5 201.0 199.9 200.6
Stockholders' Equity 830.2 800.3 779.3 775.5 765.5 745.4 712.7 704.6 678.9 653.5 614.2 593.7 566.0 560.0 542.6 510.4 480.0 474.0 448.2 435.9 401.4
Cash Flow
Operating Cash Flow 100.8 68.1 (2.9) 10.0 90.9 16.6 (10.9) 34.0 23.2 6.0 19.3 15.4 25.8 7.7 84.9 (35.9) 9.0 24.0 (12.2) 51.2 21.3
Capital Expenditure (7.9) (4) (3.1) (2.6) (1.4) (3.1) (2.5) (2.3) (2.8) (0.4) (7.1) (4.1) (2.5) (14.9) (0.9) (3.2) (1.4) (17.5) (2.8) (9.1) (7.3)
Free Cash Flow 92.9 64.1 (6.0) 7.4 89.5 13.6 (13.5) 31.7 20.4 5.6 12.2 11.3 23.3 (7.1) 84.1 (39.1) 7.7 6.5 (15.0) 42.2 14.1